Review





Similar Products

90
CEM Corporation human leukemia cell line ccrf-cem
Human Leukemia Cell Line Ccrf Cem, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+leukemia+cell+line+cem/ccrf+cem+cells/us12070505-257-9-13
Average 90 stars, based on 1 article reviews
human leukemia cell line ccrf-cem - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

96
ATCC human leukemia carcinoma cell line
Human Leukemia Carcinoma Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+leukemia+cell+line+cem/CCRF-CEM/10__62110_slash_sciencein__cbl__2024__v11__678-106-0-6
Average 96 stars, based on 1 article reviews
human leukemia carcinoma cell line - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

90
CEM Corporation human acute lymphoblastic leukemia cell line ccrf-cem
Human Acute Lymphoblastic Leukemia Cell Line Ccrf Cem, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+leukemia+cell+line+cem/ccrf+cem+cells/pm38711185-154-2-7
Average 90 stars, based on 1 article reviews
human acute lymphoblastic leukemia cell line ccrf-cem - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
CEM Corporation human leukemia cell lines ccrf-cem
Human Leukemia Cell Lines Ccrf Cem, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+leukemia+cell+line+cem/ccrf+cem+cells/pm38308434-170-13-17
Average 90 stars, based on 1 article reviews
human leukemia cell lines ccrf-cem - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
CEM Corporation human acute lymphoblastic leukemia cell line (ccrf-cem)
Human Acute Lymphoblastic Leukemia Cell Line (Ccrf Cem), supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+leukemia+cell+line+cem/ccrf+cem+cells/us11719603-674-16-21
Average 90 stars, based on 1 article reviews
human acute lymphoblastic leukemia cell line (ccrf-cem) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
CEM Corporation human leukemia carcinoma ccrf-cem cell line
In vitro cytotoxicity of benzopyran-4-one-isoxazole conjugates (at a concentration of 25 μM) towards ( a ) human leukemia carcinoma (CCRF-CEM), ( b ) human ovarian <t>adenocarcinoma</t> (SKOV-3), ( c ) human breast tumor (MDA-MB-231), ( d ) human prostate cancer (PC-3), ( e ) androgen-independent human prostate cancer (DU-145), and ( f ) human renal carcinoma (iSLK) cell lines using DMSO and standard anticancer drug doxorubicin (Dox) (at a concentration of 5 μM) as controls after 24 and 72 h. The results are shown as the percentage of control that has no compound (set at 100%). All the experiments were performed in triplicate.
Human Leukemia Carcinoma Ccrf Cem Cell Line, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+leukemia+cell+line+cem/ccrf+cem+cells/pmc10224329-63-7-6
Average 90 stars, based on 1 article reviews
human leukemia carcinoma ccrf-cem cell line - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
CEM Corporation human leukemia carcinoma cell line (ccrf-cem)
In vitro cytotoxicity of benzopyran-4-one-isoxazole conjugates (at a concentration of 25 μM) towards ( a ) human leukemia carcinoma (CCRF-CEM), ( b ) human ovarian <t>adenocarcinoma</t> (SKOV-3), ( c ) human breast tumor (MDA-MB-231), ( d ) human prostate cancer (PC-3), ( e ) androgen-independent human prostate cancer (DU-145), and ( f ) human renal carcinoma (iSLK) cell lines using DMSO and standard anticancer drug doxorubicin (Dox) (at a concentration of 5 μM) as controls after 24 and 72 h. The results are shown as the percentage of control that has no compound (set at 100%). All the experiments were performed in triplicate.
Human Leukemia Carcinoma Cell Line (Ccrf Cem), supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+leukemia+cell+line+cem/human+leukemia+cells/pmc10053436-62-25-30
Average 90 stars, based on 1 article reviews
human leukemia carcinoma cell line (ccrf-cem) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


In vitro cytotoxicity of benzopyran-4-one-isoxazole conjugates (at a concentration of 25 μM) towards ( a ) human leukemia carcinoma (CCRF-CEM), ( b ) human ovarian adenocarcinoma (SKOV-3), ( c ) human breast tumor (MDA-MB-231), ( d ) human prostate cancer (PC-3), ( e ) androgen-independent human prostate cancer (DU-145), and ( f ) human renal carcinoma (iSLK) cell lines using DMSO and standard anticancer drug doxorubicin (Dox) (at a concentration of 5 μM) as controls after 24 and 72 h. The results are shown as the percentage of control that has no compound (set at 100%). All the experiments were performed in triplicate.

Journal: Molecules

Article Title: Design, Synthesis, and Antiproliferative Activity of Benzopyran-4-One-Isoxazole Hybrid Compounds

doi: 10.3390/molecules28104220

Figure Lengend Snippet: In vitro cytotoxicity of benzopyran-4-one-isoxazole conjugates (at a concentration of 25 μM) towards ( a ) human leukemia carcinoma (CCRF-CEM), ( b ) human ovarian adenocarcinoma (SKOV-3), ( c ) human breast tumor (MDA-MB-231), ( d ) human prostate cancer (PC-3), ( e ) androgen-independent human prostate cancer (DU-145), and ( f ) human renal carcinoma (iSLK) cell lines using DMSO and standard anticancer drug doxorubicin (Dox) (at a concentration of 5 μM) as controls after 24 and 72 h. The results are shown as the percentage of control that has no compound (set at 100%). All the experiments were performed in triplicate.

Article Snippet: This panel involved human leukemia carcinoma (CCRF-CEM), human ovarian adenocarcinoma (SKOV-3), human breast tumor (MDA-MB-231), human prostate cancer (PC-3), androgen-independent human prostate cancer (DU-145), and human renal carcinoma (iSLK) cell lines.

Techniques: In Vitro, Concentration Assay, Control